Clinical Trial Update: Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety, efficacy, and pharmacokinetics of ALD518 in active rheumatoid arthritis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ALD518

Snippet

Sponsor: CSL Behring | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED